WO2023055305A1 - Dispositif de détection qualitatif de dextrane et son utilisation - Google Patents

Dispositif de détection qualitatif de dextrane et son utilisation Download PDF

Info

Publication number
WO2023055305A1
WO2023055305A1 PCT/TH2022/000034 TH2022000034W WO2023055305A1 WO 2023055305 A1 WO2023055305 A1 WO 2023055305A1 TH 2022000034 W TH2022000034 W TH 2022000034W WO 2023055305 A1 WO2023055305 A1 WO 2023055305A1
Authority
WO
WIPO (PCT)
Prior art keywords
dextran
test
band
membrane
immobilized
Prior art date
Application number
PCT/TH2022/000034
Other languages
English (en)
Inventor
Satita TAPANEEYAKORN
Original Assignee
National Science And Technology Development Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Science And Technology Development Agency filed Critical National Science And Technology Development Agency
Publication of WO2023055305A1 publication Critical patent/WO2023055305A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54346—Nanoparticles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/12—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar
    • G01N2400/14—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar alpha-D-Glucans, i.e. having alpha 1,n (n=3,4,6) linkages between saccharide units, e.g. pullulan
    • G01N2400/22—Dextran

Definitions

  • This invention relates to a device for the detection of dextran.
  • the invention relates to a test strip device for use in a competitive immunoassay for qualitative determination of dextran.
  • Dextran derived from bacteria, is a polymer of glucose.
  • the presence of dextran in sugar industry causes several difficulties during the sugar production process, for example, increased viscosity, slower filtration rate, elongated sugar crystal shape, and increased sugar loss.
  • 2017/2018 statistical analysis showed that if 1000 ppm/Brix of dextran are found in cane juice in Thailand, the loss of sugar will be up to 125 million kilograms, costing around 1.5 billion baht. This will affect the mill’s revenue and country’s economy.
  • the immunological assay for dextran has recently been introducted to the sugar industry (Proc Sug Ind Technol, 1999,58, 747).
  • the method is based on the specific binding of monoclonal antibody to dextran.
  • the reaction time is short because of rapid formation of antigen-antibody complex.
  • the turbidity of this complex can be measured by a nephelometer.
  • this method is quick and easy to use, the cost is still high for routine test of large number of samples in the agricultural product processing. Therefore, there is a need for a simple, rapid, accurate and cost-effective assay for on-site analysis of dextran in all sugar streams, providing operations to be optimized accordingly to avoid slowdowns and loss of sucrose.
  • Thai patent application number TH 1301005362 involves semiquantitative detection of dextran based on competitive immunochromatographic assay.
  • the device consists of a test band of immobilized dextran, a control band of goat anti-mouse IgG antibody, and an anti- dextramgold conjugate zone. It measures three dextran concentration levels in first juice dependent on the intensity of test band: ⁇ 1000 ppm/Brix, >1000 ppm/Brix, 1000-2000 ppm/Brix with 85% confidence interval.
  • the reading of band intensity for a large number of test samples is impractical and this device was designed for the test sample of first juice only.
  • the technology needs to be further developed for other test samples in the sugar processing, which are different in term of chemical and physical characteristics, for example the purity and the viscosity.
  • the present invention involves rapid qualitative detection of dextran related to competitive immunoassay.
  • the ratios of dextran immobilized on the test band to the antibody specific to dextran conjugated to gold nanoparticle (Au NP-anti-dextran) on the conjugate pad were optimized on the condition that the amount of immobilized dextran on the test band must be higher than signal saturation point leading to the decrease of false positive and false negative.
  • the cut off value of this device is about 900 ppm/Brix, which is useful for determining dextran impurity in the sugar processing.
  • the sensitivity, specificity and accuracy for dextran detection are 92.9%, 93.5%, and 93.3% with the reading time 5 minutes. Overall, the efficiency of this device is beter than the prior art.
  • the invention provides a device for qualitative detection of dextran in a test sample, including but not limited to sugarcane streams.
  • the device has good performance characteristics (sensitivity 92.9%, specificity 93.5%, and accuracy 93.3%) and shows the result in a short time.
  • the present invention involves a test strip for qualitative detection of dextran.
  • the device utilizes the principle of competitive immunoassay.
  • the device comprising:
  • test band (5) positioned at a certain distance from the conjugate pad, and on the opposite side of the sample pad.
  • the test band (5) has immobilized dextran for result judgement of the presence of dextran;
  • Fig.l represents the dextran detection device of the present invention in exploded sideview, composed of backing (1), sample pad (2), conjugate pad (3), membrane (4), test band (5), control band (6), absorbent pad (7), and strip cassette (8).
  • Fig.2 illustrates the top-view of dextran detection device showing sample pad (2), membrane (4), test band (5), control band (6), and strip cassette (8).
  • Fig.3 illustrates schematic diagram of competitive immunochromatography for qualitative detection of dextran.
  • Fig.4 depicts the results for 45 test samples from cane comparing the test strip device of the present invention and the haze method.
  • Fig.5 illustrates the application of the test strip device of the present invention with palmyra palm juice.
  • the present invention involves a device / test strip for qualitative detection of dextran.
  • the device utilizes the principle of competitive immunoassay.
  • the device comprising:
  • test band (5) positioned at a certain distance from the conjugate pad (3), and on the opposite side of the sample pad (2).
  • the test band (5) has immobilized dextran for result judgement of the presence of dextran;
  • the ratio of dextran immobilized on the test band (5) to the antibody specific to dextran conjugated to gold nanoparticle (Au NP-anti-dextran) on the conjugate pad (3) can be in the range from 1:1 to 1:10 (v/v) on the condition that the amount of immobilized dextran on the test band (5) must be 2-3 times of signal saturation point on the membrane (4).
  • the ratio of dextran immobilized on the test band (5) to Au NP-anti-dextran on the conjugate pad (3) can vary from 1 :4 to 1 :6 (v/v).
  • the size of gold nanoparticle can vary from 10 to 100 nm in diameter.
  • the size of gold nanoparticle can vary from 20 to 50 nm in diameter.
  • the device has the cut off value ranging from 0.1 to 0.5 mg/mL dextran
  • the device has the cut off value ranging from 0.15 to 0.3 mg/mL dextran
  • control band (6) is immobilized with secondary antibody.
  • the secondary antibody comprising at least one antibody selected from the group consisting of goat anti-mouse IgG, rabbit antimouse IgG, horse anti-mouse IgG, donkey anti-mouse IgG, or chicken anti-mouse IgG
  • the secondary antibody is goat antimouse IgG.
  • the device further comprising the strip cassete with at least 1 well and at least 1 window. The well is positioned at the sample pad (2) and the window is positioned at the test band (5) and control band (6).
  • the device further comprising absorbent pad (7), next to the control band (6), for collecting excess fluid and preventing backflow.
  • the membrane (4) comprising at least one membrane selected from the group consisting of nitrocellulose membrane, polyvinylidene fluoride, nylon, and polyestersulfone.
  • the conjugate pad (3) comprising at least one membrane selected from the group consisting of nitrocellulose membrane, cellulose filter, glass fiber, and polyester film.
  • the sample is selected from the group consisting of fresh cane juice, diluted cane juice, cane extracts, sugar crystals from cane, first juice, mixed juice, clarified juice, raw syrup, and raw sugar.
  • the anti-dextran antibody in phosphate buffer or borate buffer, pH 8.0-9.5 is mixed with gold solution containing gold nanoparticle in the preferred range from 20 to 40 nm in diameter in phosphate buffer or borate buffer, pH 8.0-9.5, and incubated at 22-28 °C for 5- 15 minutes.
  • the principle of the device in the present invention is based on competitive theory as shown in Fig.3.
  • the competition is between the migrating analyte and the immobilized analyte for the binding to the migrating Au NP-anti-dextran conjugate.
  • the test sample for example can juice
  • on the sample pad (2) of the device in the present invention for dextran determination can be undiluted or diluted with a chase buffer in the ratio of 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, or 1:10 (v/v)
  • the Au NP-anti-dextran conjugate on the conjugate pad (3) binds to the dextran in the test sample, generating the Au NP-anti-dextran-dextran complex.
  • the complex moves chromatographically on the membrane (4) to the test band (5) immobilized with dextran.
  • the test sample cane juice, travels by capillary action from the sample pad (2) to the absorbent pad.
  • the control band immobilized with the secondary antibody, which is goat anti-mouse IgG as an example in the present invention
  • the goat antimouse IgG binds to the anti-dextran antibody conjugated to gold nanoparticle in the case of test sample having no dextran and/or the Au NP-anti-dextran-dextran complex in case of test sample having dextran, providing a red color band in both cases.
  • the control band is the quality indicator of the device. Dextran determination by the device in the present invention takes about 5 minutes.
  • Example 1 Dextran analysis of pure dextran with known concentrations in cane juice
  • the device in the present invention is a strip based on the competitive immunochromatography.
  • the strip comprises sample pad (2), which is glass fiber, membrane (4), which is nitrocellulose membrane, conjugate pad, absorbent ad, and backing made from plastic.
  • control band (6) on the membrane (4) which is nitrocellulose membrane can be prepared by spraying goat anti-mouse IgG.
  • the test band (5) can be prepared by spraying dextran around 2 and 2.5 times of signal saturation point on membrane (4) for dextran detection.
  • the conjugation pad (3) can be prepared by spraying the antibody specific to dextran conjugated to gold nanoparticle by using the ratio of dextran immobilized on the test band (5) to the antibody specific to dextran conjugated to gold nanoparticle (Au NP-anti-dextran) on the conjugate pad (3) of 1 :5 (v/v). Then, the strip is enclosed within a strip cassette (8).
  • test samples are various concentrations of dextran in cane juice, which are dropped into the sample pad (2). After that, the result can be read at approximately 5 minutes.
  • the analysis can be done by red-band visualization. The negative result is indicated by two red bands on both test and control bands (5 and 6) and the positive result is indicated by a red band on the control band (6).
  • the cut off value of the device can be determined by finding the lowest concentration of dextran giving the positive result on the device as shown in Table 1.
  • the cut off value of the device in the present invention is approximately 0.2 mg/mL (between 0.2 and 0.3 mg/mL).
  • Table 1 The relationship of dextran concentrations in cane juice and color intensity on test band, providing the cut off value of dextran test strip.
  • Example 2 Dextran detection in cane juice
  • test samples from cane i.e. first juice, mixed juice, clarified juice, raw syrup, and raw sugar are used and the results are compared to a gold standard haze method.
  • the procedure for dextran analysis by the device in the present invention is as follows:
  • the test sample is applied to the sample pad.
  • the test sample can be undiluted or diluted into a buffer at a dilution of sample to buffer of about 1:1, 1:2, 1:3, 1:4, 1:5, 1:6, 1:7, 1:8, 1:9, or 1:10 (v/v).
  • the preferred ratio for the defined cut off value and the most appropriate use of the device is in the range from 1:1 to 1:5 (v/v).
  • the sample When the test sample is in the solid form, the sample must be dissolved at the concentrations about 10%-40% (w/v) before applying to the device in the present invention.
  • test result can be read at about 5 minutes
  • the amount of dextran at approximately 2 and 2.5 times of signal saturation point on the test band provides better results than those at approximately 1, 1.5 and 1.75 times of signal saturation point.
  • These results can be explained by the complexity of various structure of dextran, leading to its dynamic binding to the antibody.
  • the ratio of dextran immobilized on the test band to Au NP-anti-dextran on the conjugate pad in the range from about 1:4 to 1:10 (v/v) is also optimized and the one in combination with the optimization of dextran immobilized on the test band giving the best result is 1 :5 (v/v) as shown in Table 3-
  • the dextran detection of 45 agricultural samples by the device in the present invention indicates the approximate cut off value of the device 900 ppm/Brix.
  • the results are compared to a gold standard haze method to calculate the sensitivity, specificity, and accuracy of the device. From Table 3, the sensitivity, specificity, and accuracy of the device for dextran detection in the present invention are 92.9%, 93.5%, and 93.3%, respectively, whereas the efficiency of the prior art is about 15% lower than the device in the present invention, and its use is limited to the test sample first juice.
  • the dextran test strip in the present invention is a very efficient device and easy to use for a non-technical person. Therefore, it is a suitable device for dextran detection in the industry, helping to improve the manufacturing process.
  • Table 2 The effect of dextran quantity (times of signal saturation point) immobilized on the test band on the efficiency of qualitative dextran test strip.
  • Table 3 The performance of the dextran test strip in the present invention by using dextran two times of the signal saturation point on the test band in combination with a range of the ratio of dextran immobilized on the test band to Au NP-anti-dextran on the conjugate pad.
  • the dextran detection in palmyra palm juice is performed as described in Example 2.
  • the results indicate the successful application of the device in the present invention with the test samples from palmyra palm juice. There is no band on the test band (positive result) for the sample with approximately >900 ppm/Brix of dextran, whereas there is a red band on the test band (negative result) for the sample with approximately ⁇ 900 ppm/Brix of dextran as shown in Fig.5.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne un dispositif à bandelette réactive permettant de déterminer la présence de dextrane dans un échantillon d'essai par dosage immunologique compétitif. Le dispositif permet d'obtenir un procédé rapide, fiable, facile à utiliser et peu coûteux, qui est adapté à la détection qualitative du dextrane dans le domaine.
PCT/TH2022/000034 2021-09-28 2022-09-16 Dispositif de détection qualitatif de dextrane et son utilisation WO2023055305A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TH2101006037 2021-09-28
TH2101006037 2021-09-28

Publications (1)

Publication Number Publication Date
WO2023055305A1 true WO2023055305A1 (fr) 2023-04-06

Family

ID=85783336

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TH2022/000034 WO2023055305A1 (fr) 2021-09-28 2022-09-16 Dispositif de détection qualitatif de dextrane et son utilisation

Country Status (1)

Country Link
WO (1) WO2023055305A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100041A1 (en) * 2000-10-04 2003-05-29 Christopher Bucke Assay method
US20070166774A1 (en) * 2006-01-17 2007-07-19 Groman Ernest V Functional immunoassay
US20110229913A1 (en) * 2008-11-28 2011-09-22 Infopia Co., Ltd. Method for Amplification of Signal in Immunochromatographic Assay and Immunochromatographic Kit Using the Method
US20130281310A1 (en) * 2008-04-09 2013-10-24 Becton, Dickinson And Company Sensitive immunoassays using coated nanoparticles

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100041A1 (en) * 2000-10-04 2003-05-29 Christopher Bucke Assay method
US20070166774A1 (en) * 2006-01-17 2007-07-19 Groman Ernest V Functional immunoassay
US20130281310A1 (en) * 2008-04-09 2013-10-24 Becton, Dickinson And Company Sensitive immunoassays using coated nanoparticles
US20110229913A1 (en) * 2008-11-28 2011-09-22 Infopia Co., Ltd. Method for Amplification of Signal in Immunochromatographic Assay and Immunochromatographic Kit Using the Method

Similar Documents

Publication Publication Date Title
US5569608A (en) Quantitative detection of analytes on immunochromatographic strips
US7790400B2 (en) Delta-9-tetrahydrocannabinol detection method
US4604365A (en) Immunoprecipitation assay
US5932480A (en) Measurement method and kit for hemoglobin A1c
US5658745A (en) Cell enumeration immunoassay
Cho et al. Semiquantitative, bar code version of immunochromatographic assay system for human serum albumin as model analyte
US6835543B2 (en) Step agglutination immunoassay
EP0356964B1 (fr) Méthode pour la détermination d'une substance de liaison spécifique
DE3834766A1 (de) Verfahren zur bestimmung einer spezifisch bindefaehigen substanz
Medcalf et al. Rapid, robust method for measuring low concentrations of albumin in urine
DE60212840T2 (de) Immunassayverfahren
EP0174652A2 (fr) Procédé de mesure immunochimique pour haftènes et protéines
Tsay et al. Optical biosensor assay (OBA)
KR920000057B1 (ko) 특이적으로 결합가능한 물질의 측정 방법 및 시약
EP0328388A2 (fr) Solution de lavage, trousse d'essai et procédé pour la détermination d'un ligand immunologique
AU601434B2 (en) Methods of immunoassay
Farese et al. An automated method for the determination of serum calcium with glyoxal bis (2-hydroxyanil)
Kato et al. Fluorophotometric enzyme immunoassay of thyroid-stimulating hormone
WO2023055305A1 (fr) Dispositif de détection qualitatif de dextrane et son utilisation
WO1996019732A1 (fr) Titrages directs competitifs a linearite amelioree
US4329152A (en) Determination of β2 -microglobulin in human urine and serum by latex immunoassay
Townsend A competitive immunoenzymometric assay for albumin in urine.
EP0809805B1 (fr) Utilisation d'autoanticorps anti-htg polyclonaux humains comme reactifs pour le diagnostic clinique d'affections auto-immunes de la thyroide et jeu de reactifs servant a detecter les autoanticorps anti-htg dans les serums de patients
ES2125982T3 (es) Prueba inmunologica turbidimetrica de velocidad inicial.
Perez-Bendito et al. Direct stopped-flow fluorescence polarization immunoassay of abused drugs and their metabolites in urine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22877032

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE